Article Details

Defying the odds and beating analyst forecasts: Sonnet BioTherapeutics Holdings Inc. (SONN)

Retrieved on: 2023-01-11 05:28:54

Tags for this article:

Click the tags to see associated articles and topics

Defying the odds and beating analyst forecasts: Sonnet BioTherapeutics Holdings Inc. (SONN). View article details on hiswai:

Excerpt

... Sonnet BioTherapeutics Announces a Collaboration with Roche for the ... to be evaluated in combination with Roche's atezolizumab (Tecentriq®).

Article found on: investchronicle.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up